In response to IL4, TAMs acquire the ability to upregulate expression of insulin-like growth factor 1 (IGF-1), which triggers the signaling of IGF-1R and PI3K, rendering the tumor resistant to CSF-1R inhibition (33, 98). Here, CSF1R is linked to neoplasm.